Hepatitis c virus inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 403/14 (2006.01) A61K 31/4439 (2006.01) A61K 31/444 (2006.01) A61K 31/497 (2006.01) A61K 31/501 (2006.01) A61K 31/506 (2006.01) A61P 31/12 (2006.01) C07D 401/14 (2006.01)

Patent

CA 2660628

The present disclosure relates to compounds of formula (I), or a pharmaceutically acceptable salt thereof, wherein A and B are selected from phenyl and a six-membered heteroaromatic ring containing one, two or three nitrogen atoms; provided that at least one of A and B is other than phenyl, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

La présente invention concerne des composés, des compositions et des méthodes pour le traitement d'une infection par le virus de l'hépatite C (VHC). L'invention concerne également des compositions pharmaceutiques contenant ces composés ainsi que des méthodes d'utilisation de ces composés dans le traitement d'une infection par le VHC.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Hepatitis c virus inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hepatitis c virus inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis c virus inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1724394

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.